Sophie Cousins


Sophie Cousins is a health writer based in India. She was previously based between Lebanon and Iraq focusing on refugee health and conflict. She is particularly interested in infectious diseases and rural health in South Asia. She writes for international medical journals, including The Lancet, and for international news websites such as Al-Jazeera English.

Latest Articles

Overcoming challenges to a TB epidemic
7 Nov 2016

As the world looks towards the future of eliminating tuberculosis, many challenges remain including sustainable funding, improving treatment completion and the issue of latent infection. How can these obstacles be overcome? Devex takes a closer look.

Private sector provides opportunity to improve Myanmar's health outcomes
10 Oct 2016

While the government of Myanmar is increasing its spending on health care, the expansion of the private sector is providing an opportunity to expand services and improve access. Devex takes a look inside Asia's newest emerging market.

Experts call for urgent HIV testing scale-up to reach global goals
1 Aug 2016

With only 51 percent of people living with HIV know their status, experts say innovations around testing must be made available and brought to scale — especially for key populations at greatest risk of acquiring the virus. Here's how data can help.

Barriers to PrEP: Rollout of this HIV prevention tool is hitting bumps
22 Jul 2016

Experts have raised concerns about health care systems and social barriers to the effective roll out of a pill to prevent HIV infection among key populations.

Step by step: The road to ending the AIDS epidemic
18 Jul 2016

Are we on course to end the AIDS epidemic by 2030? As #AIDS2016 begins in Durban, South Africa, Devex talks to Michel Sidibé, executive director at UNAIDS, about scaling up access to treatment, issues around new prevention tools and self testing, and the uncertainty of future funding.

Making a fundamental shift in drug policy and harm reduction
17 May 2016

In efforts to limit the transmission of bloodborne infectious diseases, particularly HIV and hepatitis B and C, governments and civil society are exploring harm reduction efforts. These public health policies are designed as practical responses for people who are unable or unwilling to stop using drugs, and they could shift the global war on drugs.

Nepal: A year on from the earthquake
25 Apr 2016

While nongovernmental organizations and volunteers were quick to respond to last year's Nepal earthquake, the official reconstruction process has languished. Devex takes a closer look at progress exactly one year on from the disaster.

The right dose, the right chance: India's battle with drug-resistant TB
24 Mar 2016

More than 60,000 people in India have drug-resistant TB in India, according to the World Health Organization. What major steps are needed help address this issue? To mark World Tuberculosis Day, Devex visited local facilities and staff working to combat the epidemic, and got the inside track.

Combating meningitis in sub-Saharan Africa and what the future holds
16 Mar 2016

In sub-Saharan countries that use meningitis A vaccine, the disease has been virtually wiped out. Devex explores the campaign's success and how can it can inform other vaccination efforts on the continent.

UHC: A viable proposition for India?
26 Nov 2015

Important questions have been raised over India's ability to deliver universal health coverage in a country of more than 1.2 billion, when it only spends just over 1 percent of its gross domestic product on health. Can India deliver on its UHC promise? Devex takes a closer look.